An international team of including the Lomonosov Moscow State University researchers discovered which enzyme enables Escherichia coli bacterium (E. coli) to breathe. The study is published in the Scientific Reports.
There is a prospect of a new type of antibiotics “turning off” the oxygen only to the harmful bacteria cells, not to human cells.
Scientists discovered how the E. coli bacterium can survive in the human gut – earlier the question how they breathe was a mystery to experts. Vitaliy Borisov, Senior Researcher, Doctor of Biological Sciences, Professor of the Russian Academy of Sciences, A.N. Belozersky Research Institute physical and chemical biology employee, the Lomonosov Moscow State University and one of the authors, explains that breathing E. coli uses special enzymes, which are absent in the human body. This means that the discovery of the scientists can contribute to the creation of new drugs, which will be detrimental to the bacteria without harming a human.
The energy for the vital activity of any organism comes from food, and is generated by the means of redox processes in the body. The food is converted into energy not directly but through intermediaries. First, the complex molecules are decomposed into simpler: proteins are decomposed into amino acids, fats – to fatty acids, carbohydrates – to monosaccharides. Oxidation of simpler molecules releases energy, which all is contained in the electrons.
The electrons passes to the respiratory chain with the so-called reducing equivalents (electron-carrying compound). They are NADH (nicotinamide adenine dinucleotide) and ubiquinol, also known as coenzyme Q. These two basic reducing equivalents fully cope with the processing of food: NADH is a water-soluble compound and ubiquinol is fat-soluble. Membranous enzymes accept electrons from reducing equivalents and transfer them to molecular oxygen.
The terminal cytochrome oxidase is the main membrane enzyme responsible for the human mitochondrial respiration and was thought to be used for the breath of E. coli as well. The scheme of oxidases action is simple: transferring electrons to molecular oxygen, reducing equivalents are oxidized again, and as a result “the energy currency” of the cell – the proton-moving force is generated.
‘If you stop breathing, you die just because oxygen does not flow to the oxidase, and it does not produce energy,’ said Vitaly Borisov.
The Escherichia coli bacterium lives in the gastrointestinal tract, where a lot of hydrogen sulfide is produced, which attenuates mitochondrial respiration. Free hydrogen sulfide inhibits cytochrome oxidase work. Its concentration exceeds several hundred times the minimum concentration required for substantial blocking of this enzyme. Hence, it seems that the E. coli bacterium cannot “breathe”, but despite that the bacteria somehow survive in the intestine. The researchers assumed that the breath in the presence of hydrogen sulfide is still possible, but due to other oxidase. The fact is that the breath in people and bacteria occur in different ways. Each cell in our body “breathes” due to the work of only the cytochrome-c oxidase, others we have not. However, the E. coli bacteria has two types of oxidase: bo-type cytochrome oxidase (analogue of “human” cytochrome-c oxidase) and completely different bd-type cytochromes.
‘Our hypothesis was that the bd-type oxidase (bd-I and bd-II) are more resistant to the hydrogen sulfide inhibition than the bo-type cytochrome oxidase,’ commented Vitaly Borisov.
To test this hypothesis scientists needed to learn how the sulfide presence in the environment affects the growth of the E. coli bacteria cells, which have only one terminal oxidase (bd-I, bd-II or bo) in the respiratory chain. a variety of biochemical, biophysical and microbiological methods and approaches were applied, as well as the method of the intended mutagenesis.
The hypothesis was fully confirmed.
‘Bo-oxidase’s activity is completely inhibited by the hydrogen sulfide, while the work of the bd-oxidases remains untouched by the H2S. Thus, in order to successfully produce the main types of “the energy currency” under a high concentration of hydrogen sulfide, the intestinal microflora inhabitants should use a unique type of terminal oxidases, which is missing in the cells of humans and animals,’ said Vitaly Borisov.
The discovery could be used in the future to develop medicines that regulate the intestinal microflora and relieving it from harmful bacteria. As human cells do not contain the bd-type oxidase, the question of the ability to combat disease-causing bacteria without causing harm to the human body becomes relevant. For example, the bacterium causing tuberculosis, which’s primarily membrane enzyme is also a bd-type oxidase, quickly gaining resistance to classical antibiotics. Through this study there is a prospect of a new type of antibiotics “turning off” the oxygen only to the harmful bacteria cells, not to human cells.
The Latest on: Revolutionary Antibiotics
via Google News
The Latest on: Revolutionary Antibiotics
- Get ready for a counter revolution on February 7, 2019 at 5:33 am
I pack antibiotics, a humidifier ... It’s even worth a blog topic, this counter revolution. I walked through the Motto by Hilton room build-out at the recent Americas Lodging Investment Summit confere... […]
- Zurik: HHS Secretary says ‘revolutionary’ changes to come for drug prices on February 7, 2019 at 2:05 am
METAIRIE, LA (WVUE) - A law signed by President Donald Trump as a result of the ‘Medical Waste’ Investigation is the start of ‘revolutionary’ changes ... We also found an antibiotic for $143 in the U. ... […]
- New drugs needed to fight global antibiotics crisis on February 6, 2019 at 9:04 pm
However, I wanted to highlight some other potential solutions. Through the second half of the last century society benefited from an antibiotic revolution. The discovery of new mechanism antibiotics a... […]
- Using CRISPR to fight antibiotic-resistant ‘superbugs’ on February 5, 2019 at 5:09 am
Researchers discovered the biosynthetic pathway of an antibiotic called malonomycin using CRISPR/Cas9, the revolutionary and sometimes controversial gene-editing tool. “Antibiotic resistance is ... […]
- 'Unhealthy' Food Production Makes Healthy Eating Impossible, Report Claims on January 25, 2019 at 12:30 am
Excessive use of pesticides, antibiotics in livestock farming ... The report says that cities are key to instigating a ‘food revolution’, with 80% of food consumption set to take place in cities by 20... […]
- CRISPR explained: The revolutionary tool that's transforming genetic engineering on January 23, 2019 at 5:00 am
We are in the midst of a gene-editing revolution. For four decades ... combat invasive species and destroy antibiotic-resistant bacteria. Many unknowns remain, however, including how CRISPR might dama... […]
- Build a Better Gut By Avoiding Gut Enemy #1: Antibiotics on July 31, 2018 at 1:20 pm
"Antibiotics are equal opportunity drugs," Dr. Wenzel said, "They kill the good guys as well as the bad guys. Dr. Gerard Mullin associate professor of medicine at The Johns Hopkins Hospital and author ... […]
- Big data targets drug resistance on June 15, 2018 at 2:01 pm
Experts who are adept at handling massive scientific data sets are examining ways that the revolution sweeping their field can ... and one of the organizers of a symposium on the topic, said antibioti... […]
- UW develops plans to use interactive maps to visualize antibiotic resistance data on April 3, 2018 at 5:31 am
“I never expected that I’d be working on something related to antibiotic resistance.” Madison-based company will test ‘revolutionary’ universal flu vaccine this springFluGen, a Madison company founded ... […]
- Stay strong and become an antibiotics ambassador on March 11, 2018 at 11:24 pm
GPs and our teams can be effective antibiotic resistance ambassadors From Fleming’s discovery of penicillin nearly 90 years ago, they have been hailed as wonder-drugs that have played a part in the he... […]
via Bing News